Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Condition:   Rhabdomyosarcoma Interventions:   Drug: Vincristine;   Drug: Dactinomycin;   Drug: Cyclophosphamide;   Procedure: Surgical Resection;   Procedure: Proton beam radiation or external beam radiation or brachytherapy;   Drug: Liposomal irinotecan;   Drug: Vinorelbine;   Drug: Temozolomide;   Drug: Filgrastim, peg- filgrastim Sponsor:   St. Jude Children's Research Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials